RUVBL1 and YY1 promote tumor growth (Wang et al., 2015; Fan et al., 2017), and inhibiting RUVBL1 expression in metastatic breast cancer cells can reduce both cell proliferation and invasion (Fan et al., 2017). Here, YY1 is linked to breast cancer.